Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma

NCT05656144 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DEVICE: Cadonilimab

Sponsor

Peking University Cancer Hospital & Institute